We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+7.76%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.75B
AUM Growth
+$529M
Cap. Flow
+$146M
Cap. Flow %
3.08%
Top 10 Hldgs %
47.97%
Holding
745
New
128
Increased
150
Reduced
259
Closed
162
Avg Time Held Equity + Options
3.8 quarters
Top 10 Avg Time Held Equity + Options
1.1 quarters
Top 20 Avg Time Held Equity + Options
1.1 quarters
Avg Time Held Equity only
3.9 quarters
Top 10 Avg Time Held Equity only
1.1 quarters
Top 20 Avg Time Held Equity only
1.1 quarters

Top Buys

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$253M
2
PDCE
PDC Energy, Inc.
PDCE
+$210M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$206M
4
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$135M
5
LSI
Life Storage, Inc.
LSI
+$87.5M

Top Sells

Rank Stock Value
1
FHN icon
First Horizon
FHN
+$179M
2
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
+$146M
3
PRVB
Provention Bio, Inc. Common Stock
PRVB
+$70.5M
4
TSEM icon
Tower Semiconductor
TSEM
+$50.8M
5
XM
Qualtrics International Inc. Class A Common Stock
XM
+$45.3M

Sector Composition

Rank Sector Weight
1 Healthcare 32.35%
2 Technology 15.68%
3 Financials 11.99%
4 Miscellaneous 10.5%
5 Real Estate 8.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
AAT icon
301
American Assets Trust
AAT
$1.32B
$1.79M 0.04%
+93,281
New +$1.75M
2023 Q2
0 quarters
VRDN icon
302
Viridian Therapeutics
VRDN
$2.11B
$1.78M 0.04%
74,836
+11,293
+18% +$290K
2022 Q1
5 quarters
GRTX icon
303
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$1.78M 0.04%
570,506
-143,025
-20% -$426K
2023 Q1
1 quarter
JAZZ icon
304
Jazz Pharmaceuticals
JAZZ
$14.2B
$1.76M 0.04%
14,214
-12,610
-47% -$1.7M
2022 Q1
5 quarters
ALGN icon
305
Align Technology
ALGN
$10.2B
$1.73M 0.04%
4,891
-234
-5% -$74.5K
2022 Q4
2 quarters
LCID icon
306
PUT
Lucid Motors
LCID
$1.36B
$1.73M 0.04%
+70,000
New +$4.99M
2023 Q2
0 quarters
HHLA
307
DELISTED
HH&L Acquisition Co.
HHLA
$1.7M 0.04%
162,326
-3,658
-2% -$38.1K
2021 Q3
7 quarters
CCK icon
308
Crown Holdings
CCK
$11.9B
$1.67M 0.04%
+19,224
New +$1.58M
2023 Q2
0 quarters
QURE icon
309
uniQure
QURE
$1.5B
$1.65M 0.03%
143,965
+68,890
+92% +$1.31M
2022 Q4
2 quarters
BCRX icon
310
BioCryst Pharmaceuticals
BCRX
$2.13B
$1.64M 0.03%
232,463
+6,699
+3% +$53.8K
2022 Q1
5 quarters
CORS
311
DELISTED
Corsair Partnering Corporation
CORS
$1.61M 0.03%
155,244
-3,499
-2% -$36K
2021 Q3
7 quarters
ETNB icon
312
DELISTED
89bio
ETNB
$1.59M 0.03%
83,838
+27,899
+50% +$490K
2022 Q3
3 quarters
CVNA icon
313
PUT
Carvana
CVNA
$44.1B
$1.57M 0.03%
5,000,000
– –
2023 Q1
1 quarter
NBR icon
314
Nabors Industries
NBR
$1.22B
$1.57M 0.03%
+16,850
New +$1.71M
2023 Q2
0 quarters
OCUL icon
315
Ocular Therapeutix
OCUL
$1.67B
$1.56M 0.03%
302,111
-61,175
-17% -$364K
2022 Q1
5 quarters
SNOW icon
316
Snowflake
SNOW
$127B
$1.55M 0.03%
+8,805
New +$1.43M
2023 Q2
0 quarters
ICLR icon
317
Icon
ICLR
$12.7B
$1.54M 0.03%
6,145
-173
-3% -$36.7K
2022 Q2
4 quarters
ALCYU icon
318
DELISTED
Alchemy Investments Acquisition Corp 1 Units
ALCYU
$1.54M 0.03%
+150,000
New +$1.52M
2023 Q2
0 quarters
FNA icon
319
DELISTED
Paragon 28, Inc.
FNA
$1.53M 0.03%
86,285
+61,485
+248% +$1.1M
2023 Q1
1 quarter
SRRK icon
320
Scholar Rock
SRRK
$5.13B
$1.53M 0.03%
202,581
+67,025
+49% +$506K
2022 Q2
4 quarters
ANNX icon
321
Annexon
ANNX
$760M
$1.5M 0.03%
425,556
+258,649
+155% +$1.13M
2022 Q1
5 quarters
XENE icon
322
Xenon Pharmaceuticals
XENE
$3.48B
$1.49M 0.03%
38,676
-24,715
-39% -$982K
2022 Q1
5 quarters
RDNW icon
323
RideNow Group
RDNW
$192M
$1.47M 0.03%
118,896
-31,104
-21% -$290K
2022 Q2
4 quarters
AONC icon
324
DELISTED
American Oncology Network, Inc. Class A Common Stock
AONC
$1.47M 0.03%
142,301
-3,239
-2% -$33.2K
2021 Q2
8 quarters
DNLI icon
325
Denali Therapeutics
DNLI
$3.04B
$1.44M 0.03%
+48,952
New +$1.38M
2023 Q2
0 quarters
11 12
13
14 15

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q2 2023 Portfolio in Review

As of Q2 2023, UBS O'Connor held 745 positions worth $4.75B, up 13% from $4.22B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

UBS O'Connor deployed $146M of net new capital in Q2 2023, opening 128 new positions and adding to 150 existing holdings. Its largest new stake was PDC Energy, Inc.: 3,101,445 shares worth $221M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 21% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Tower Semiconductor, an estimated $50.8M trimmed.

  • UBS O'Connor's largest Q2 2023 buy was PDC Energy, Inc.: 3,101,445 shares worth $221M.
  • UBS O'Connor added most to Seagen Inc. Common Stock in Q2 2023, an estimated $253M increase.
  • UBS O'Connor's biggest Q2 2023 reduction was Tower Semiconductor, cutting an estimated $50.8M.
  • UBS O'Connor fully exited First Horizon in Q2 2023, selling an estimated $179M.
  • UBS O'Connor's ten largest holdings make up 48% of its $4.75B portfolio in Q2 2023.
  • UBS O'Connor opened 128 new positions and closed 162 in Q2 2023.
  • UBS O'Connor's portfolio value rose 13% quarter-over-quarter to $4.75B.

Based on UBS O'Connor's 13F filing for Q2 2023, filed 14 Aug 2023.